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Effect of a Chinese herbal medicine on chronic 
periodontitis patients 
J. KANG1, Y.-Q. SHA2, L. JIN3, and C.-F. CAO1, 1Peking University, School of Stomatology, Beijing, China, 2Peking University, Beijing, China, 3University 
of Hong Kong, Hong Kong  
Objectives: A randomized, single-blinded case-controlled trial was designed to evaluate the effect of a Chinese herbal medicine (HM) as adjunct of 
scaling and root planning (SRP) in advanced chronic periodontitis (CP) patients. Methods: 30 advanced CP patients (7M,23F) aged 20 to 45 years old 
were enrolled . Subjects were generally healthy, non-smokers,and had no periodontal treatment before. Each patient had at least 3 teeth in each 
quadrant with PD>5mm,CAL>3mm. From each patient 5-6 most severely diseased tooth sites were monitored throughout the study. Periodontal 
parameters including probing depth (PD) and clinical attachment loss (AL) using Florida Probe, bleeding index (BI), and GCF volume were recorded at 
baseline and 3,6,9,12 months after treatment. Alveolar bone was analyzed by digital subtraction radiography (DSR) at baseline and 6,12 months. All 
subjects received thorough full mouth SRP. Then,they were randomly assigned to test group (15 patients, 82 sites) and control group (15 patients, 78 
sites). Group-T orally took a marketed HM named BUSHEN GUCHIWAN (4.0g, bid) for three months. Group-C took no medicine. During each recall 
visit both groups received OHI and prophylaxis and clinical parameters recorded. Results: 24 patients attended 6-month recall. 13 patients completed 
12-month survey. Both groups showed significant improvement in all parameters after treatment at all visits. However, group-T showed additional 
improvements. At 6-month, PD reduced 2.48mm in group-T compared to 2.19mm in group-C; AL improved 1.61mm and 1.08mm, respectively; GCF 
reduced 0.37µl in group-T vs 0.26µl in group-C; BI decreased 1.45 and 1.32, respectively. The inter-group differences in clinical data peaked at 6-
month (P<0.01). DSR analysis showed the increased bone density in group-T was 4.99±2.76 vs 3.27±2.28 in group-C (P<0.05) at 6-month and 
continued growing until 12-month (6.54±3.01 vs 4.30±3.38, P<0.05). Conclusions: The “Bushen Guchiwan” may contribute to the adjunct effect of 
SRP for advanced chronic periodontitis patients.  
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